Joi Women’s Wellness is presented within the current Joi + Blokes service. Its hormone page lists a progesterone capsule and a progesterone cream at different prices. That visible distinction is useful, but neither the shared hormone name nor a monthly price display explains the complete preparation or purchase. The same page also discusses quarterly care and possible compounded products.
This September 29, 2026 review examines those separate pieces of the public offer. It does not verify a supplied medicine, compounding pharmacy, laboratory result, clinical encounter or checkout. Questions about an oral capsule remain tied to the exact preparation a clinician might propose.
In this article
A capsule listing does not establish a finished-product label
Joi’s hormone-care page lists progesterone capsules at $54 per month and cream at $69 per month. The page says medicines ship and bill quarterly, so these monthly figures do not establish a one-month purchase. The capsule entry supports a relevant product offering, but the page does not identify its strength, complete inactive ingredients or a particular manufacturer. An illustration on the page is expressly qualified as potentially different from the actual medicine.
Request the proposed prescription and dispensing information before treating that illustration or category as a label. Wisp’s review highlights another menu where exact identity matters, because micronized progesterone appears near a different oral drug. The comparison should begin with what each product actually is, rather than assume all progesterone-related offers describe interchangeable capsules.
The cream cannot borrow the capsule’s evidence
The Joi catalog presents capsule and cream as separate forms. This does not establish equivalent absorption, clinical effect or suitability for the same purpose. A cheaper or more convenient form cannot be selected from the page as though the route were merely a packaging preference.
The medicine-purpose guide helps ask why a particular preparation is included. FDA menopause guidance addresses the importance of evaluated hormone therapies and the limits of compounded bioidentical claims. The clinician should explain what evidence supports the actual formulation and intended role. This review cannot transfer oral-product findings to a skin preparation or certify uterine protection from a broad hormone description.
The compounding notice changes the approval question
Joi’s product page says some medicines may be compounded and not FDA-approved. That notice does not identify every listed capsule as compounded, but it prevents an assumption that each offer is an approved finished product. The approval status of the preparation being proposed needs its own answer.
FDA’s compounding resource explains that the agency does not review compounded drugs for safety, effectiveness or quality before marketing. The capsule-excipient guide also distinguishes the active ingredient from the whole formula. Ask for the pharmacy, full ingredients and reason for the preparation. Neither a bioidentical description nor an unspecified plant origin settles those matters or demonstrates superior safety.
Quarterly billing is more than a monthly headline
The current hormone page lists care at $50 per month billed quarterly, with medicines charged separately. It describes clinician visits and ongoing laboratory work as included, while initial panels appear separately at $149, $399 and $699 before a new-customer discount banner. The page does not resolve every initial-lab and selected-order total.
A separate offer uses a different lab promotion and lists a $35 fee per three-month estrogen or progesterone prescription sent to a local pharmacy for possible insurance use. That fee should not silently be added to, or omitted from, every arrangement. Request the chosen care, medicine, lab and pharmacy charges together, with their actual quarterly units and any applicable introductory conditions.
Cancellation wording and insurance routes need clarification
The hormone page contains broad cancel-anytime language and also says cancellation follows the first three months. Its separate offer similarly describes an initial three-month commitment. These statements leave a material question about the selected agreement rather than establish a no-commitment purchase.
The service says certain prescriptions can go to a local pharmacy where insurance may apply, while it does not bill insurance directly for the broader program. Alloy’s review examines another difference between medicine shipments and care access. Neither company’s terms establish the other’s. Confirm the actual recurring charge and cancellation process; no refund or cancellation was tested here.
Brain and sleep claims still need an individual clinical purpose
Joi’s FAQ language discusses progesterone beyond uterine-lining protection, including sleep, mood and cognition. Those broad statements do not determine that a person without a uterus needs a prescription, nor establish a preventive benefit from the particular capsule listed. FDA guidance says hormone therapy should not be used to prevent memory loss or Alzheimer’s disease.
The page’s patient survey and testimonials likewise do not isolate the capsule’s effect. MedlinePlus identifies possible dizziness and drowsiness with oral progesterone. Our drowsiness guide supports a practical discussion about unwanted effects without recasting sedation as proof that treatment is working or suggesting a personal change in use.
A coach can help route a question without answering the prescription
Joi’s service information describes coaches as a point of contact and liaison, while stating that they do not diagnose, prescribe or provide specific medical advice. That boundary matters when the question concerns capsule ingredients, an unclear instruction or a possible adverse effect. The appropriate clinician or pharmacist must address those issues.
The follow-up guide helps identify who handles each part of care. The documented offer includes progesterone capsules, but the review cannot identify the eventual formula, establish a complete quarterly total or promise benefit. A clear professional explanation should connect the medicine’s purpose, preparation, pharmacy record and follow-up responsibility before marketing language is treated as a finished treatment plan.
Sources for this article
Source type matters. A provider page describes an offer; an exact product label describes that medicine.
- Joi + Blokes: hormone care and progesterone listingsProvider capsule versus cream, separate quarterly charges, compounding notice and promotional claims; exact capsule identity, first-lab total and cancellation wording unresolved · Checked 2026-09-29
- FDA: MenopauseCurrent federal patient guidance; product-dependent benefits/risks and prevention limits, no personal eligibility or class-wide label-change inference · Checked 2026-09-29
- FDA: Understanding the Risks of Compounded DrugsFederal regulatory explanation; compounded preparations are not FDA-approved, no inference about inspection or quality of a named pharmacy · Checked 2026-09-29
- Joi + Blokes: separate HRT offerDated distinct offer with different lab promotion and local-pharmacy prescription fee; not silently merged into all current orders · Checked 2026-09-28
- MedlinePlus: ProgesteroneFederal medication information; oral-capsule identity, possible dizziness/drowsiness and professional discussion only; public schedules not reproduced as reader instructions · Checked 2026-09-29
- Joi + Blokes: service and coach rolesDated provider homepage; coach role expressly excludes diagnosis/prescribing/specific medical advice; no individual service result verified · Checked 2026-09-28